期刊文献+

两种大鼠肺动脉高压模型转化生长因子-β1及其Ⅰ型受体表达的比较 被引量:2

Comparison of expression of TGF-β1 and TGF-βR1 in two types of pulmonary artery hypertension model of rats
原文传递
导出
摘要 目的观察转化生长因子(TGF)-β1及其Ⅰ型受体在两种大鼠肺动脉高压模型中表达的变化。方法36只Spargue—Dawley大鼠,对照组、分流型和药物型肺动脉高压模型各12只,使用原位杂交方法观察TGF—β1及其Ⅰ型受体在肺小动脉表达的定位,并使用逆转录一聚合酶链反应(RT—PCR)法观察两者mRNA转录量的变化。结果大鼠分流型与药物型肺动脉高压模型中TGF—β1及其Ⅰ型受体mRNA主要分布于肺小动脉内皮细胞和外膜成纤维细胞,两种模型中TGF—β1(1.17±0.09、1.09±0.07)及其Ⅰ型受体(0.80±0.06、0.93±0.02)mRNA转录均较对照组明显增加,三组间均数比较差异有统计学意义(P〈0.05)。结论TGF-β1信号参与了肺动脉高压肺血管重塑的过程,但在不同的模型中作用机制不同。 Objective To compare the different expression of TGF-β1 and TGF-βR1 in two types of pulmonary artery hypertension model of rats. Methods Thirty-six Spargue-Dawley rats were divided into 3 groups (control, carotid artery-jugular vein shunt pulmonary hypertension model and monocrotalin-in- duced pulmonary hypertension model). Each group had 12 rats. TGF-β1 and TGF-βR I localization was evaluated by in situ hybridization, and mRNA transcription was detected by RT-PCR. Results The locali- zations of TGF-β1 and TGF-13R I in two models were endothelial cells and extima fibroblast cells of pulmonary arteries, respectively. The expression of TGF-β1 ( 1.17 ± 0.09,1.09 ±0. 07) and TGF-βR I mRNA (0.80± 0.06,0.93± 0.02) was increased in both two models. There was significant difference in multiple comparison of three groups (P 〈 0.05). Conclusion TGF-β1 signaling is involved in pulmonary vascular remodeling of pulmonary hypertension process, and its mechanisms in two pulmonary artery hypertension models are different.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第6期767-769,共3页 Chinese Journal of Experimental Surgery
基金 广东省科技计划基金资助项目(2008B030301076)
关键词 肺动脉高压 转化生长因子-Β1 Ⅰ型受体表达 临床 医学 Hypertension,pulmonary Transforming growth factor beta 1
  • 相关文献

参考文献8

  • 1齐建光,杜军保,李简,汤秀英,魏冰,唐朝枢.左向右分流所致肺动脉高压大鼠模型的建立及其肺血管结构的变化[J].中华实验外科杂志,2002,19(3):199-200. 被引量:28
  • 2陈晓辉,翁国星,林群.一种新型的大鼠肺动脉高压模型[J].中华实验外科杂志,2005,22(7):882-882. 被引量:9
  • 3Mandergar M, Fung YCB, Huang W, et al. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvas Res, 2004,68 : 75 -103.
  • 4Rabinovitch M. Pathobiology of pulmonary hypertension. Extracellular matrix. Clin Chest Med ,2001,22:433-449.
  • 5Eickelberg O, Morty RE. Transforming growth factor beta/bone morphogenic protein signaling in pulmonary arterial hypertension:remodeling revisited. Trends Cardiovasc Med ,2007,17:263-269.
  • 6Govinden R, Bhoola KD. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Therapeut, 2003,98 : 257 -265.
  • 7Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med,2006,10:76-99.
  • 8Neubauer K, Scaile B, Ramadori G. Liver fibrosis and altered matrix synthesis, Can J Gastroenterol,2001,15 : 187-193.

二级参考文献7

共引文献33

同被引文献19

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部